United States · Platforms & data · MarketBeat
BioNTech Q3 Earnings Call Highlights
BioNTech (NASDAQ:BNTX) reported third-quarter 2026 revenue of €1.3 billion, down from €1.5 billion a year earlier, as lower demand for its COVID-19 vaccine weighed on results. The…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




